Analyst Ratings:
Analyst sentiment for for Friday September 25th,across North American markets was selectively bullish. Technology, health care and industrials drew several positive calls, while Canadian energy also saw higher targets. Consumer, financial and real estate ratings were more mixed, with target cuts tempering the stronger recommendations. The combined outlook points to opportunities in specific sectors, but limited evidence of a broad market rally.
Canadian Analyst Ratings (51 Entries)
Air Canada (AC:CA) — Scotiabank maintained its Outperform rating with a C$37.50 target price.
Alimentation Couche-Tard (ATD:CA) — Scotiabank maintained its Outperform rating with a C$102.00 target price.
Allied Properties REIT (AP.UN:CA) — Scotiabank assigned a C$10.50 target price.
AltaGas (ALA:CA) — Scotiabank maintained its Outperform rating with a C$62.00 target price.
Altius Minerals (ALS:CA) — Scotiabank maintained its Sector Perform rating with a C$65.00 target price.
Aritzia (ATZ:CA) — RBC Capital lowered its target price to C$191.00 from C$202.00 while maintaining its Outperform rating.
Athabasca Oil (ATH:CA) — Scotiabank maintained its Sector Perform rating with a C$11.00 target price.
Auxly Cannabis Group (XLY:CA) — Acumen Capital maintained its Buy rating with a C$5.00 target price.
B2Gold (BTO:CA) — Scotiabank maintained its Outperform rating with a C$10.00 target price.
Bank of Montreal (BMO:CA) — Scotiabank maintained its Sector Outperform rating with a C$270.00 target price.
Baytex Energy (BTE:CA) — Scotiabank maintained its Outperform rating with a C$7.50 target price.
BCE-Inc. (BCE:CA) — Scotiabank maintained its Outperform rating with a C$40.00 target price.
Birchcliff Energy (BIR:CA) — Scotiabank maintained its Sector Perform rating with a C$7.75 target price.
BlackBerry (BB:CA) — TD Securities maintained its Hold rating with a C$11.00 target price.
Bombardier (BBD.B:CA) — RBC Capital maintained its Outperform rating with a C$406.00 target price.
Bombardier (BBD.B:CA) — Scotiabank maintained its Outperform rating with a C$380.00 target price.
Brookfield Infrastructure Partners (BIP-UN:CA) — TD Securities maintained its Buy rating with a C$80.00 target price.
Brookfield Renewable Partners (BEP-UN:CA) — TD Securities maintained its Buy rating with a C$55.00 target price.
Canadian Imperial Bank of Commerce (CM:CA) — Scotiabank maintained its Sector Perform rating with a C$174.00 target price.
Canadian National Railway (CNR:CA) — Scotiabank maintained its Outperform rating with a C$199.00 target price.
Canadian Natural Resources (CNQ:CA) — Desjardins Securities raised its target price to C$73.00 from C$70.00 while maintaining its Hold rating.
Canadian Tire (CTC-A:CA) — Scotiabank maintained its Sector Perform rating with a C$200.00 target price.
Cenovus Energy (CVE:CA) — Desjardins Securities raised its target price to C$52.00 from C$50.00 while maintaining its Buy rating.
Chorus Aviation (CHR:CA) — RBC Capital maintained its Outperform rating with a C$39.00 target price.
Enbridge (ENB:CA) — Scotiabank maintained its Outperform rating with a C$84.00 target price.
Fairfax Financial Holdings (FFH:CA) — Scotiabank maintained its Outperform rating with a C$2,950.00 target price.
First Mining Gold (FF:CA) — National Bank raised its target price to C$1.50 from C$1.30 while maintaining its Outperform rating.
First Quantum Minerals (FM:CA) — Scotiabank maintained its Outperform rating with a C$53.00 target price.
FirstService (FSV:CA) — TD Securities maintained its Buy rating with a C$276.00 target price.
HEALWELL AI (AIDX:CA) — Scotiabank maintained its Outperform rating with a C$1.50 target price.
Imperial Oil (IMO:CA) — Scotiabank maintained its Sector Perform rating with a C$156.00 target price.
Imperial Oil (IMO:CA) — Desjardins Securities raised its target price to C$165.00 from C$160.00 while maintaining its Hold rating.
Loblaw Companies (L:CA) — Scotiabank maintained its Sector Perform rating with a C$67.00 target price.
Martinrea International (MRE:CA) — CIBC maintained its Outperform rating with a C$12.50 target price.
Meren Energy (MER:CA) — Scotiabank maintained its Sector Perform rating with a C$2.50 target price.
Russel Metals (RUS:CA) — RBC Capital maintained its Outperform rating with a C$92.00 target price.
Sangoma Technologies (STC:CA) — TD Securities maintained its Buy rating with a C$9.00 target price.
Slate Grocery REIT (SGR.U:CA) — CIBC lowered its target price to C$8.25 from C$12.00.
Spin Master (TOY:CA) — CIBC maintained its Neutral rating with a C$23.00 target price.
Suncor Energy (SU:CA) — Desjardins Securities raised its target price to C$110.00 from C$107.00 while maintaining its Buy rating.
The Cronos Group (CRON:CA) — TD Securities raised its target price to C$7.00 from C$6.00 while maintaining its Buy rating.
Total Energy Services (TOT:CA) — RBC Capital initiated coverage with a Sector Perform rating and a C$41.00 target price.
Tourmaline Oil (TOU:CA) — Jefferies raised its target price to C$72.00 from C$71.00.
Tourmaline Oil (TOU:CA) — Desjardins Securities raised its target price to C$69.00 from C$68.00 while maintaining its Hold rating.
Transcontinental (GIB-A:CA) — CIBC maintained its Outperform rating with a C$7.00 target price.
Vecima Networks (VCM:CA) — Acumen Capital raised its target price to C$24.00 from C$18.00 while maintaining its Buy rating.
Vecima Networks (VCM:CA) — Raymond James raised its target price to C$19.00 from C$18.00 while maintaining its Outperform rating.
Vecima Networks (VCM:CA) — B. Riley raised its target price to C$22.00 from C$21.00.
Whitecap Resources (WCP:CA) — Desjardins Securities raised its target price to C$23.00 from C$22.00 while maintaining its Buy rating.
WildBrain (WILD:CA) — ATB Cormark lowered its target price to C$1.35 from C$1.70 while maintaining its Sector Perform rating.
WildBrain (WILD:CA) — National Bank lowered its target price to C$1.50 from C$1.75 while maintaining its Sector Perform rating.
U.S. Analyst Ratings (259 Entries)
3M (MMM) — Sanford C. Bernstein upgraded the stock from Underperform to Market Perform and raised its price target to $171.00 from $145.00.
Abeona Therapeutics (ABEO) — UBS Group reiterated its Buy rating.
Abeona Therapeutics (ABEO) — HC Wainwright reiterated its Buy rating.
Acadian Asset Management (AAMI) — Morgan Stanley raised its price target to $95.00 from $81.00 and maintained an Equal Weight rating.
ACADIA Pharmaceuticals (ACAD) — Needham & Company lowered its price target to $35.00 from $41.00 and maintained a Buy rating.
ACADIA Pharmaceuticals (ACAD) — Deutsche Bank lowered its price target to $31.00 from $38.00 and maintained a Buy rating.
ACADIA Pharmaceuticals (ACAD) — HC Wainwright lowered its price target to $33.00 from $37.00 and maintained a Buy rating.
ACADIA Pharmaceuticals (ACAD) — Citizens JMP lowered its price target to $33.00 from $36.00 and maintained a Market Outperform rating.
ACADIA Pharmaceuticals (ACAD) — Citigroup reiterated its Buy rating and lowered its price target to $33.00 from $40.00.
Accenture (ACN) — JPMorgan Chase raised its price target to $200.00 from $179.00 and maintained an Overweight rating.
Akamai Technologies (AKAM) — Bank of America raised its price target to $185.00 from $175.00 and maintained a Buy rating.
Akamai Technologies (AKAM) — UBS Group raised its price target to $148.00 from $143.00 and maintained a Neutral rating.
Akamai Technologies (AKAM) — Guggenheim raised its price target to $225.00 from $190.00 and maintained a Buy rating.
Akamai Technologies (AKAM) — TD Cowen raised its price target to $149.00 from $140.00 and maintained a Hold rating.
Akamai Technologies (AKAM) — Evercore reiterated its Outperform rating.
Akamai Technologies (AKAM) — JPMorgan Chase raised its price target to $167.00 from $158.00 and maintained a Neutral rating.
Akamai Technologies (AKAM) — Piper Sandler reiterated its Overweight rating and raised its price target to $158.00 from $125.00.
Akamai Technologies (AKAM) — DA Davidson reiterated its Buy rating with a $185.00 price target.
Akamai Technologies (AKAM) — RBC Capital reiterated its Sector Perform rating with a $135.00 price target.
Alaska Air Group (ALK) — Raymond James reiterated its Outperform rating.
Aligos Therapeutics (ALGS) — Jefferies upgraded the stock to Strong Buy.
Ally Financial (ALLY) — Citigroup lowered its price target to $50.00 from $58.00 and maintained a Buy rating.
Almonty Industries (ALM) — Stifel initiated coverage with a Buy rating and a $25.00 price target.
Alta Equipment Group (ALTG) — Citigroup reiterated its Outperform rating.
Alta Equipment Group (ALTG) — Northland Securities set a $12.00 price target.
AMC Entertainment (AMC) — Citigroup reiterated its Sell rating and raised its price target to $2.20 from $1.80.
Ameren (AEE) — RBC Capital lowered its price target to $107.00 from $114.00 and maintained a Sector Perform rating.
Andersen Group (ANDG) — Truist Financial raised its price target to $70.00 from $55.00 and maintained a Buy rating.
Apple (AAPL) — Sanford C. Bernstein reiterated its Outperform rating.
Arthur J. Gallagher & Co. (AJG) — Morgan Stanley lowered its price target to $285.00 from $290.00 and maintained an Overweight rating.
Ascendis Pharma (ASND) — Cantor Fitzgerald reiterated its Overweight rating with a $300.00 price target.
Assured Guaranty (AGO) — Roth Capital upgraded the stock from Neutral to Buy and raised its price target to $85.00 from $80.00.
AxoGen (AXGN) — Raymond James raised its price target to $53.00 from $48.00 and maintained an Outperform rating.
Axsome Therapeutics (AXSM) — HC Wainwright reiterated its Buy rating.
Axsome Therapeutics (AXSM) — Morgan Stanley lowered its price target to $247.00 from $251.00 and maintained an Equal Weight rating.
Bank of New York Mellon (BNY) — Truist Financial lowered its price target to $172.00 from $178.00 and maintained a Buy rating.
Biodesix (BDSX) — HC Wainwright reiterated its Buy rating and raised its price target to $38.00 from $27.00.
BlackBerry (BB) — Canaccord Genuity lowered its price target to $9.50 from $10.30 and maintained a Hold rating.
BlackRock (BLK) — Morgan Stanley lowered its price target to $1,479.00 from $1,488.00 and maintained an Overweight rating.
Block (XYZ) — BTIG Research reiterated its Buy rating with a $100.00 price target.
Block (XYZ) — Cantor Fitzgerald reiterated its Overweight rating with a $95.00 price target.
BP (BP) — HSBC upgraded the stock from Hold to Buy and raised its price target to $51.30 from $46.00.
Brightstar Lottery (BRSL) — Stifel set a $19.00 price target.
Brixmor Property Group (BRX) — Piper Sandler reiterated its Overweight rating.
Camden Property Trust (CPT) — Truist Financial lowered its price target to $108.00 from $123.00 and maintained a Buy rating.
Cardinal Infrastructure Group (CDNL) — Truist Financial initiated coverage with a Buy rating and a $40.00 price target.
CarMax (KMX) — Stephens raised its price target to $74.00 from $66.00 and maintained an Overweight rating.
CF Industries (CF) — Sanford C. Bernstein initiated coverage with an Outperform rating and a $162.00 price target.
Charles River Laboratories (CRL) — Barclays raised its price target to $330.00 from $300.00 and maintained an Overweight rating.
Charles River Laboratories (CRL) — TD Cowen raised its price target to $325.00 from $300.00 and maintained a Buy rating.
Charles River Laboratories (CRL) — RBC Capital raised its price target to $322.00 from $282.00 and maintained an Outperform rating.
Charles River Laboratories (CRL) — Robert W. Baird raised its price target to $334.00 from $291.00 and maintained an Outperform rating.
Charles River Laboratories (CRL) — Mizuho raised its price target to $295.00 from $264.00 and maintained a Neutral rating.
Charles River Laboratories (CRL) — Deutsche Bank raised its price target to $320.00 from $300.00 and maintained a Buy rating.
Charles River Laboratories (CRL) — Evercore set a $330.00 price target.
Charter Communications (CHTR) — Morgan Stanley lowered its price target to $140.00 from $150.00 and maintained an Equal Weight rating.
Charter Communications (CHTR) — Goldman Sachs lowered its price target to $110.00 from $120.00 and maintained a Sell rating.
Chemed (CHE) — UBS Group initiated coverage with a Buy rating and a $650.00 price target.
Chevron (CVX) — HSBC raised its price target to $250.00 from $218.00 and maintained a Buy rating.
Chevron (CVX) — UBS Group set a $250.00 price target.
Cipher Mining (CIFR) — HC Wainwright reiterated its Buy rating.
Cognizant Technology Solutions (CTSH) — Daiwa Securities raised its price target to $60.00 from $42.00 and maintained a Neutral rating.
Comcast (CMCSA) — Morgan Stanley lowered its price target to $27.00 from $29.00 and maintained an Equal Weight rating.
Comstock Resources (CRK) — Jefferies initiated coverage with a Hold rating and a $14.00 price target.
Consensus Cloud Solutions (CCSI) — BTIG Research reiterated its Buy rating with a $50.00 price target.
Constellation Brands (STZ) — JPMorgan Chase lowered its price target to $133.00 from $165.00 and maintained a Neutral rating.
Costco Wholesale (COST) — Roth Capital reiterated its Sell rating with a $781.00 price target.
Costco Wholesale (COST) — TD Cowen reiterated its Buy rating.
Costco Wholesale (COST) — Robert W. Baird set a $1,175.00 price target.
Costco Wholesale (COST) — BMO Capital Markets reiterated its Outperform rating.
Costco Wholesale (COST) — HSBC upgraded the stock to Buy.
Costco Wholesale (COST) — Raymond James lowered its price target to $1,050.00 from $1,100.00 and maintained an Outperform rating.
Costco Wholesale (COST) — Sanford C. Bernstein lowered its price target to $1,143.00 from $1,144.00 and maintained an Outperform rating.
Costco Wholesale (COST) — Mizuho lowered its price target to $1,065.00 from $1,100.00 and maintained an Outperform rating.
Costco Wholesale (COST) — RBC Capital reiterated its Sector Perform rating with a $1,000.00 price target.
Costco Wholesale (COST) — Wells Fargo lowered its price target to $950.00 from $1,000.00 and maintained an Equal Weight rating.
Costco Wholesale (COST) — JPMorgan Chase lowered its price target to $1,015.00 from $1,100.00 and maintained an Overweight rating.
Costco Wholesale (COST) — Truist Financial lowered its price target to $955.00 from $1,011.00 and maintained a Hold rating.
Costco Wholesale (COST) — DA Davidson raised its price target to $1,040.00 from $1,000.00 and maintained a Neutral rating.
Costco Wholesale (COST) — Jefferies lowered its price target to $1,100.00 from $1,130.00.
Coya Therapeutics (COYA) — HC Wainwright reiterated its Buy rating.
Cracker Barrel Old Country Store (CBRL) — Citigroup raised its price target to $44.00 from $42.00 and maintained a Sell rating.
Cullinan Therapeutics (CGEM) — HC Wainwright raised its price target to $35.00 from $30.00 and maintained a Buy rating.
Cullinan Therapeutics (CGEM) — BTIG Research reiterated its Buy rating with a $40.00 price target.
Damora Therapeutics (DMRA) — Guggenheim raised its price target to $60.00 from $40.00 and maintained a Buy rating.
Darden Restaurants (DRI) — Sanford C. Bernstein reiterated its Outperform rating with a $230.00 price target.
Darden Restaurants (DRI) — BTIG Research reiterated its Buy rating with a $235.00 price target.
Darden Restaurants (DRI) — Stephens reiterated its Equal Weight rating with a $220.00 price target.
Darden Restaurants (DRI) — BMO Capital Markets lowered its price target to $220.00 from $225.00 and maintained a Market Perform rating.
Darden Restaurants (DRI) — Mizuho raised its price target to $245.00 from $235.00 and maintained an Outperform rating.
Darden Restaurants (DRI) — Guggenheim reiterated its Buy rating with a $235.00 price target.
Darden Restaurants (DRI) — Citigroup lowered its price target to $247.00 from $248.00 and maintained a Buy rating.
D.R. Horton (DHI) — Evercore set a $166.00 price target.
Eastman Chemical (EMN) — Jefferies reiterated its Buy rating with a $85.00 price target.
Emerson Electric (EMR) — Wells Fargo initiated coverage with an Overweight rating and a $177.00 price target.
Emerson Electric (EMR) — TD Cowen raised its price target to $170.00 from $150.00 and maintained a Hold rating.
Everpure (P) — Barclays raised its price target to $132.00 from $110.00 and maintained an Equal Weight rating.
Fervo Energy (FRVO) — Wolfe Research upgraded the stock from Peer Perform to Outperform with a $29.00 price target.
Fervo Energy (FRVO) — Bank of America lowered its price target to $30.00 from $36.00 and maintained a Buy rating.
Fidelity National Information Services (FIS) — Robert W. Baird lowered its price target to $45.00 from $48.00 and maintained a Neutral rating.
Five Below (FIVE) — Goldman Sachs reiterated its Buy rating with a $306.00 price target.
Fortune Brands Innovations (FBIN) — Evercore set a $45.00 price target.
Franklin Resources (BEN) — Morgan Stanley raised its price target to $35.00 from $34.00 and maintained an Equal Weight rating.
Gen Digital (GEN) — RBC Capital lowered its price target to $26.00 from $30.00 and maintained a Sector Perform rating.
Generac (GNRC) — UBS Group reiterated its Buy rating.
General Mills (GIS) — Barclays raised its price target to $37.00 from $36.00 and maintained an Equal Weight rating.
Genius Sports (GENI) — JPMorgan Chase initiated coverage with an Overweight rating and a $8.00 price target.
GoDaddy (GDDY) — Robert W. Baird raised its price target to $120.00 from $110.00 and maintained an Outperform rating.
Goldman Sachs (GS) — Wells Fargo lowered its price target to $1,175.00 from $1,325.00 and maintained an Overweight rating.
Grab (GRAB) — Bank of America reiterated its Buy rating.
GRAIL (GRAL) — Mizuho raised its price target to $100.00 from $65.00 and maintained a Neutral rating.
Gulfport Energy (GPOR) — Jefferies downgraded the stock from Buy to Hold and lowered its price target to $180.00 from $239.00.
H. B. Fuller (FUL) — Robert W. Baird lowered its price target to $65.00 from $75.00 and maintained an Outperform rating.
Honeywell International (HON) — Wells Fargo initiated coverage with an Equal Weight rating and a $231.00 price target.
Honeywell International (HON) — Rothschild & Co Redburn lowered its price target to $234.00 from $237.00 and maintained a Neutral rating.
Humana (HUM) — Barclays upgraded the stock from Equal Weight to Overweight and raised its price target to $515.00 from $407.00.
Infleqtion (INFQ) — BTIG Research reiterated its Buy rating with a $25.00 price target.
Installed Building Products (IBP) — Evercore set a $222.00 price target.
Invesco (IVZ) — Morgan Stanley raised its price target to $31.00 from $30.00 and maintained an Equal Weight rating.
Ironwood Pharmaceuticals (IRWD) — Jefferies upgraded the stock to Hold.
JPMorgan Chase (JPM) — Jefferies reiterated its Neutral rating.
Kimberly-Clark (KMB) — Bank of America lowered its price target to $120.00 from $122.00 and maintained a Buy rating.
Kinross Gold (KGC) — CIBC lowered its price target to $50.00 from $54.00 and maintained an Outperformer rating.
Knife River (KNF) — B. Riley lowered its price target to $65.00 from $105.00 and maintained a Buy rating.
Kodiak AI (KDK) — Chardan Capital reiterated its Buy rating with a $12.00 price target.
Kopin (KOPN) — Stifel set a $6.50 price target.
Kyverna Therapeutics (KYTX) — Benchmark reiterated its Buy rating.
Kyverna Therapeutics (KYTX) — HC Wainwright reiterated its Buy rating.
Kyverna Therapeutics (KYTX) — Needham & Company set a $25.00 price target.
L3Harris Technologies (LHX) — Argus downgraded the stock from Buy to Hold.
Lennox International (LII) — Wells Fargo initiated coverage with an Equal Weight rating and a $424.00 price target.
Ligand Pharmaceuticals (LGND) — Barclays initiated coverage with an Overweight rating and a $345.00 price target.
Lionsgate Studios (LION) — JPMorgan Chase initiated coverage with an Underweight rating and a $9.00 price target.
LyondellBasell Industries (LYB) — UBS Group lowered its price target to $62.00 from $64.00 and maintained a Neutral rating.
McDonald’s (MCD) — Sanford C. Bernstein reiterated its Market Perform rating.
McDonald’s (MCD) — HC Wainwright set a $250.00 price target.
Medline (MDLN) — UBS Group lowered its price target to $43.00 from $45.00 and maintained a Buy rating.
Meritage Homes (MTH) — Evercore set a $65.00 price target.
Merlin (MRLN) — Canaccord Genuity initiated coverage with a Buy rating and a $7.50 price target.
Meta Platforms (META) — Deutsche Bank raised its price target to $820.00 from $750.00 and maintained a Buy rating.
Meta Platforms (META) — TD Cowen raised its price target to $865.00 from $750.00 and maintained a Buy rating.
Meta Platforms (META) — Canaccord Genuity raised its price target to $950.00 from $930.00 and maintained a Buy rating.
Meta Platforms (META) — Piper Sandler raised its price target to $875.00 from $785.00 and maintained an Overweight rating.
Moderna (MRNA) — Sanford C. Bernstein reiterated its Market Perform rating.
Mohawk Industries (MHK) — Evercore set a $129.00 price target.
Morgan Stanley (MS) — Wells Fargo lowered its price target to $223.00 from $240.00 and maintained an Equal Weight rating.
Natera (NTRA) — RBC Capital raised its price target to $460.00 from $350.00 and maintained an Outperform rating.
Nektar Therapeutics (NKTR) — BTIG Research reiterated its Buy rating with a $178.00 price target.
Nike (NKE) — Goldman Sachs lowered its price target to $38.00 from $42.00 and maintained a Neutral rating.
Nike (NKE) — Bank of America downgraded the stock from Neutral to Underperform and lowered its price target to $30.00 from $47.00.
Oklo (OKLO) — UBS Group reiterated its Neutral rating and lowered its price target to $41.00 from $55.00.
Okta (OKTA) — Stephens raised its price target to $240.00 from $190.00 and maintained an Overweight rating.
Okta (OKTA) — Robert W. Baird raised its price target to $235.00 from $200.00 and maintained an Outperform rating.
Okta (OKTA) — BMO Capital Markets raised its price target to $230.00 from $187.00 and maintained an Outperform rating.
Park National (PRK) — Hovde Group initiated coverage with a Market Perform rating and a $190.00 price target.
Park National (PRK) — National Bank Financial set a $190.00 price target.
Park National (PRK) — Piper Sandler reiterated its Neutral rating.
Paychex (PAYX) — TD Cowen lowered its price target to $105.00 from $117.00 and maintained a Hold rating.
PayPal (PYPL) — Deutsche Bank reiterated its Hold rating with a $55.00 price target.
PDF Solutions (PDFS) — Needham & Company initiated coverage with a Buy rating and a $60.00 price target.
PetMed Express (PETS) — Morgan Stanley lowered its price target to $1.40 from $2.15 and maintained an Underweight rating.
Planet Fitness (PLNT) — UBS Group reiterated its Overweight rating.
Porch Group (PRCH) — Cantor Fitzgerald raised its price target to $20.00 from $18.00 and maintained an Overweight rating.
Precigen (PGEN) — B. Riley initiated coverage with a Buy rating and a $12.00 price target.
Prime Medicine (PRME) — Chardan Capital reiterated its Buy rating with a $7.00 price target.
Prime Medicine (PRME) — Citigroup reiterated its Market Outperform rating.
Progress Software (PRGS) — Jefferies upgraded the stock to Hold.
PulteGroup (PHM) — Evercore reiterated its Outperform rating.
Pursuit Attractions and Hospitality (PRSU) — Citigroup initiated coverage with an Outperform rating.
Pursuit Attractions and Hospitality (PRSU) — Citizens JMP initiated coverage with a Market Outperform rating and a $64.00 price target.
Restaurant Brands International (QSR) — Argus downgraded the stock from Buy to Hold.
Rezolute (RZLT) — Citigroup reiterated its Market Outperform rating.
Rezolute (RZLT) — HSBC upgraded the stock to Buy.
Rezolute (RZLT) — HC Wainwright raised its price target to $10.00 from $5.00 and maintained a Buy rating.
Seaport Therapeutics (SPTX) — Raymond James initiated coverage with a Strong Buy rating and a $46.00 price target.
ServiceTitan (TTAN) — TD Cowen reiterated its Buy rating with a $100.00 price target.
Sherwin-Williams (SHW) — Wells Fargo lowered its price target to $340.00 from $360.00 and maintained an Equal Weight rating.
Solaris Energy Infrastructure (SEI) — Wells Fargo reiterated its Outperform rating with a $85.00 price target.
Southern (SO) — Citigroup lowered its price target to $104.00 from $114.00 and maintained a Buy rating.
Sprouts Farmers Market (SFM) — Deutsche Bank lowered its price target to $77.00 from $84.00 and maintained a Hold rating.
Stem (STEM) — UBS Group upgraded the stock from Neutral to Buy with a $7.00 price target.
Summit Therapeutics (SMMT) — Citigroup reiterated its Market Outperform rating.
Surrozen (SRZN) — HC Wainwright reiterated its Buy rating and raised its price target to $54.00 from $44.00.
Target (TGT) — Goldman Sachs reiterated its Neutral rating.
TD SYNNEX (SNX) — Morgan Stanley raised its price target to $359.00 from $334.00 and maintained an Overweight rating.
TD SYNNEX (SNX) — UBS Group raised its price target to $379.00 from $352.00 and maintained a Buy rating.
TELA Bio (TELA) — UBS Group set a $2.00 price target.
TELA Bio (TELA) — Craig Hallum initiated coverage with a Buy rating and a $2.00 price target.
Telix Pharmaceuticals (TLX) — HC Wainwright reiterated its Buy rating with a $20.00 price target.
Tesla (TSLA) — RBC Capital reiterated its Buy rating.
Texas Roadhouse (TXRH) — Evercore set a $220.00 price target.
Thermo Fisher Scientific (TMO) — Deutsche Bank reiterated its Buy rating with a $720.00 price target.
T-Mobile US (TMUS) — Goldman Sachs lowered its price target to $211.00 from $230.00 and maintained a Buy rating.
Toll Brothers (TOL) — Evercore set a $184.00 price target.
TotalEnergies (TTE) — HSBC upgraded the stock from Hold to Buy.
Tower Semiconductor (TSEM) — Mizuho initiated coverage with an Outperform rating and a $300.00 price target.
Trane Technologies (TT) — Wells Fargo initiated coverage with an Overweight rating and a $536.00 price target.
Trevi Therapeutics (TRVI) — Oppenheimer reiterated its Outperform rating.
Triumph Financial (TFIN) — Raymond James lowered its price target to $84.00 from $89.00 and maintained an Outperform rating.
T. Rowe Price (TROW) — Morgan Stanley lowered its price target to $110.00 from $116.00 and maintained an Equal Weight rating.
UiPath (PATH) — UBS Group lowered its price target to $14.00 from $19.00 and maintained a Neutral rating.
Vaxcyte (PCVX) — Needham & Company reiterated its Buy rating with a $110.00 price target.
Victory Capital (VCTR) — Morgan Stanley raised its price target to $115.00 from $91.00 and maintained an Equal Weight rating.
Virtus Investment Partners (VRTS) — Morgan Stanley lowered its price target to $120.00 from $130.00 and maintained an Underweight rating.
Wealthfront (WLTH) — Needham & Company initiated coverage with a Buy rating and a $13.00 price target.
Welltower (WELL) — Jefferies upgraded the stock to Strong Buy.
Western Union (WU) — Monness Crespi & Hardt lowered its price target to $5.00 from $6.00 and maintained a Sell rating.
Westlake (WLK) — UBS Group lowered its price target to $98.00 from $106.00 and maintained a Buy rating.
WisdomTree (WT) — Morgan Stanley raised its price target to $27.00 from $21.00 and maintained an Equal Weight rating.
W.P. Carey (WPC) — Citigroup reported a change in its rating from Hold to Market Perform.
W.W. Grainger (GWW) — Barclays lowered its price target to $1,172.00 from $1,185.00 and maintained an Underweight rating.
Zscaler (ZS) — RBC Capital raised its price target to $236.00 from $210.00 and maintained an Outperform rating.
Zscaler (ZS) — Mizuho raised its price target to $220.00 from $210.00 and maintained an Outperform rating.
Zscaler (ZS) — Guggenheim reiterated its Buy rating.
More Ratings:
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.